ArticleStem cell research & therapy2020

Prophylactic therapy with human amniotic fluid stem cells improved survival in a rat model of lipopolysaccharide-induced neonatal sepsis through immunomodulation via aggregates with peritoneal macrophages.

Yu Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.